Drugs / DTaP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07112144 Comparator | Jun 2025 → Jun 2032 expected | diphtheria, tetanus | Changchun BCHT Biotechnology Co. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07112144 ↗ |
| Modality | Vaccine | “combined vaccine” NCT07112144 ↗ |